BIOC Stock News - Fidelity Apr 01, 2020 · Shares of Biocept Inc. (BIOC) plummeted 42% on very heavy volume in morning trading Monday, after the provider of liquid cancer tests announced the pricing of stock offering at a deep discount.The company said it agreed on the issuance and sale of 23 million shares of common stock to several institutional investors, which would increase the shares outstanding by about 54%, according … Biocept, Inc. (BIOC) CEO Michael Nall on Q4 2019 Results ... Biocept, Inc. (NASDAQ:BIOC) Q4 2019 Results Earnings Conference Call March 25, 2020 4:30 PM ET Company Participants Jody Cain - LHA, IR Michael Nall - President & CEO Tim Kennedy - SVP, Operations
The existence of unissued and unreserved common stock and preferred stock may enable our board of directors to issue shares to persons friendly to current management or to issue preferred stock
Mar 5, 2020 The reverse split follows a 1-for-10 split in March 2018 and four reverse splits in 2017 that increased the stock price by a multiple of 18,000 that Shares of Biocept Inc. plummeted 42% on very heavy volume in morning trading Monday, after the provider of liquid cancer tests announced the pricing of stock We expect to implement a 1-for-10 reverse stock split of our outstanding common stock just before the In depth view into BIOC (Biocept) stock including the latest price, news, dividend about buying stock in American Eagle Outfitters, Biocept, Ciena Corp, Cronos Brookfield Asset Management Inc. BAM_A:CA, 3:2, 2/13/2020, 2/28/2020, 4/2/ 2020. Entheos Capital Corp. ENTH_H:CA, 1:10, 3/30/2020, 4/1/2020, 4/1/2020. Nov 1, 2019 Form S-1 filed by Biocept Inc with the security and exchange commission. resulting from stock splits, stock dividends or similar transactions. BIOC Split History
Biocept, Inc. (BIOC) Stock Price, Quote, History & News ...
Biocept, Inc. (BIOC) Split History | Seeking Alpha See Biocept, Inc. (BIOC) history of stock splits. Includes date and ratio. BIOC Stock Price, Forecast & News (Biocept) | MarketBeat Biocept's stock was trading at $0.3769 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, BIOC stock has decreased by 28.2% and is now trading at $0.2706. View which stocks have been mosted impacted by Coronavirus.